Paul J. Mellett Jr.
Net Worth

Last updated:

What is Paul J. Mellett Jr. net worth?

The estimated net worth of Mr. Paul J. Mellett Jr. is at least $17,399,460 as of 6 Dec 2024. He owns shares worth $769,447 as insider, has earned $9,279,773 from insider trading and has received compensation worth at least $7,350,240 in Enanta Pharmaceuticals, Inc..

What is the salary of Paul J. Mellett Jr.?

Mr. Paul J. Mellett Jr. salary is $612,520 per year as Senior Vice President of Fin. & Admin. and Chief Financial Officer in Enanta Pharmaceuticals, Inc..

How old is Paul J. Mellett Jr.?

Mr. Paul J. Mellett Jr. is 70 years old, born in 1955.

What stocks does Paul J. Mellett Jr. currently own?

As insider, Mr. Paul J. Mellett Jr. owns shares in one company:

Company Title Shares Price per share Total value
Enanta Pharmaceuticals, Inc. (ENTA) Senior Vice President of Fin. & Admin. and Chief Financial Officer 91,710 $8.39 $769,447

What does Enanta Pharmaceuticals, Inc. do?

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

ENTA logo
ENTA
Enanta Pharmaceuticals, Inc.
$8.39

Paul J. Mellett Jr. insider trading

Enanta Pharmaceuticals, Inc.

Mr. Paul J. Mellett Jr. has made 23 insider trades between 2013-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,591 units of ENTA stock worth $20,883 on 6 Dec 2024.

The largest trade he's ever made was exercising 92,132 units of ENTA stock on 12 Mar 2014. As of 6 Dec 2024 he still owns at least 91,710 units of ENTA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 2,591 $8.06 $20,883
Sale
Common Stock 2,412 $9.63 $23,228
Option
Stock Option (Right to Buy) 10,440 $14 $146,160
Option
Common Stock 10,440 $14 $146,160
Sale
Common Stock 10,340 $44.43 $459,406
Sale
Common Stock 100 $43.96 $4,396
Sale
Common Stock 800 $54.41 $43,528
Sale
Common Stock 4,200 $53.64 $225,288
Option
Common Stock 2,812 $14.18 $39,874
Option
Stock Option (Right to Buy) 2,812 $14.18 $39,874
Option
Common Stock 4,148 $14.18 $58,819
Option
Stock Option (Right to Buy) 4,148 $14.18 $58,819
Option
Common Stock 3,480 $11.77 $40,960
Option
Stock Option (right to buy) 3,480 $11.77 $40,960
Sale
Common Stock 6,000 $45.58 $273,462
Option
Restricted Stock Units 2,625 N/A N/A
Option
Common Stock 2,625 N/A N/A
Option
Common Stock 3,480 $2.54 $8,850
Option
Stock Option (right to buy) 3,480 $2.54 $8,850
Option
Stock Option (right to buy) 1,740 $1.21 $2,100
Option
Common Stock 1,740 $1.21 $2,100
Sale
Common Stock 10,000 $61.24 $612,410
Option
Restricted Stock Units 2,625 N/A N/A
Option
Common Stock 2,625 N/A N/A
Option
Stock Option (right to buy) 6,960 $1.51 $10,503
Option
Common Stock 6,960 $1.51 $10,503
Option
Stock Option (right to buy) 6,960 $1.98 $13,802
Option
Common Stock 6,960 $1.98 $13,802
Sale
Common Stock 15,000 $120.17 $1,802,490
Sale
Common Stock 9,000 $86.87 $781,848
Option
Common Stock 29,274 $2.97 $87,061
Option
Stock Option (right to buy) 29,274 $2.97 $87,061
Option
Common Stock 13,378 $1.29 $17,298
Option
Stock Option (right to buy) 6,689 $1.29 $8,649
Sale
Common Stock 6,000 $31.23 $187,368
Sale
Common Stock 7,500 $40.1 $300,743
Sale
Common Stock 7,500 $39.78 $298,350
Sale
Common Stock 7,500 $43.92 $329,370
Sale
Common Stock 7,500 $46.39 $347,895
Sale
Common Stock 7,500 $42.51 $318,810
Sale
Common Stock 24,000 $40.13 $963,096
Sale
Common Stock 4,500 $49.5 $222,737
Sale
Common Stock 6,000 $47.87 $287,196
Sale
Common Stock 4,000 $45.3 $181,180
Sale
Common Stock 10,000 $40.16 $401,630
Sale
Common Stock 10,000 $39.13 $391,280
Sale
Common Stock 20,000 $40.16 $803,180
Option
Stock Option (right to buy) 14,680 $0.73 $10,760
Option
Common Stock 92,132 $0.73 $67,533
Option
Stock Option (right to buy) 84,265 $0.73 $61,766
Option
Common Stock 84,265 $0.73 $61,766

Enanta Pharmaceuticals key executives

Enanta Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: